Affiliation:
1. Department of Pulmonary and Critical Care Medicine State Key Laboratory of Respiratory Health and Multimorbidity, Targeted Tracer Research and Development Laboratory, Med‐X Center for Manufacturing, Frontiers Science Center for Disease‐related Molecular Network, West China Hospital, West China School of Medicine, Sichuan University Chengdu China
2. Machine Intelligence Laboratory College of Computer Science Sichuan University Chengdu China
3. Department of Laboratory Medicine West China Hospital, Sichuan University Chengdu China
Abstract
AbstractDeep learning, transforming input data into target prediction through intricate network structures, has inspired novel exploration in automated diagnosis based on medical images. The distinct morphological characteristics of chest abnormalities between drug‐resistant tuberculosis (DR‐TB) and drug‐sensitive tuberculosis (DS‐TB) on chest computed tomography (CT) are of potential value in differential diagnosis, which is challenging in the clinic. Hence, based on 1176 chest CT volumes from the equal number of patients with tuberculosis (TB), we presented a Deep learning‐based system for TB drug resistance identification and subtype classification (DeepTB), which could automatically diagnose DR‐TB and classify crucial subtypes, including rifampicin‐resistant tuberculosis, multidrug‐resistant tuberculosis, and extensively drug‐resistant tuberculosis. Moreover, chest lesions were manually annotated to endow the model with robust power to assist radiologists in image interpretation and the Circos revealed the relationship between chest abnormalities and specific types of DR‐TB. Finally, DeepTB achieved an area under the curve (AUC) up to 0.930 for thoracic abnormality detection and 0.943 for DR‐TB diagnosis. Notably, the system demonstrated instructive value in DR‐TB subtype classification with AUCs ranging from 0.880 to 0.928. Meanwhile, class activation maps were generated to express a human‐understandable visual concept. Together, showing a prominent performance, DeepTB would be impactful in clinical decision‐making for DR‐TB.
Funder
National Natural Science Foundation of China
Sichuan University
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献